Avexa Limited

ASX:AVX ISIN:AU000000AVX1

Research and development of anti-infective treatments for HIV, Hepatitis B and antibiotic resistant bacteria. 
 
      

View in Other Languages

News

Avexa Limited ASX: AVX - Collaboration Agreement on HIV Drug Program - Dr Julian Chick, CEO

🕔4/19/2007 2:07:00 PM 2985

Avexa Limited (ASX: AVX) - Collaboration Agreement on HIV Drug Program - Dr Julian Chick, CEO; Boardroomradio is pleased to announce that Avexa Limited (ASX: AVX) has published an audio file.

Read Full Article

Avexa Limited ASX: AVX - Phase IIb Results for Apricitabine (ATC) - Dr Julian Chick, CEO & Dr Jonathan Coates, Chief Scientific Officer

🕔3/21/2007 12:55:00 PM 2517

Avexa Limited (ASX: AVX) - Phase IIb Results for Apricitabine (ATC) - Dr Julian Chick, CEO & Dr Jonathan Coates, Chief Scientific Officer; Boardroomradio is pleased to announce that Avexa Limited (ASX: AVX) has published an audio file.

Read Full Article
###

131,891 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 102) (Last 30 Days: 236) (Since Published: 25735) 

Company Data

    Fax
  • (03) 9208 4356 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2004/09/23 
  • Homepage
  • www.avexa.com.au